ID   TNIK_HUMAN              Reviewed;        1360 AA.
AC   Q9UKE5; A7E2A3; A8K4U1; D3DNQ6; O60298; Q8WUY7; Q9UKD8; Q9UKD9;
AC   Q9UKE0; Q9UKE1; Q9UKE2; Q9UKE3; Q9UKE4;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-MAR-2017, entry version 167.
DE   RecName: Full=TRAF2 and NCK-interacting protein kinase;
DE            EC=2.7.11.1;
GN   Name=TNIK; Synonyms=KIAA0551;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAF03782.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7 AND 8),
RP   FUNCTION, TISSUE SPECIFICITY, INTERACTION WITH TRAF2 AND NCK, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=10521462; DOI=10.1074/jbc.274.43.30729;
RA   Fu C.A., Shen M., Huang B.C., Lasaga J., Payan D.G., Luo Y.;
RT   "TNIK, a novel member of the germinal center kinase family that
RT   activates the c-Jun N-terminal kinase pathway and regulates the
RT   cytoskeleton.";
RL   J. Biol. Chem. 274:30729-30737(1999).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3] {ECO:0000305}
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-769, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [9]
RP   FUNCTION, INTERACTION WITH RAP2A, SUBCELLULAR LOCATION,
RP   AUTOPHOSPHORYLATION, AND MUTAGENESIS OF LYS-54.
RX   PubMed=15342639; DOI=10.1074/jbc.M406370200;
RA   Taira K., Umikawa M., Takei K., Myagmar B.-E., Shinzato M.,
RA   Machida N., Uezato H., Nonaka S., Kariya K.;
RT   "The Traf2- and Nck-interacting kinase as a putative effector of Rap2
RT   to regulate actin cytoskeleton.";
RL   J. Biol. Chem. 279:49488-49496(2004).
RN   [10]
RP   INTERACTION WITH TANC1.
RX   PubMed=18930710; DOI=10.1016/j.bbrc.2008.10.038;
RA   Nonaka H., Takei K., Umikawa M., Oshiro M., Kuninaka K.,
RA   Bayarjargal M., Asato T., Yamashiro Y., Uechi Y., Endo S., Suzuki T.,
RA   Kariya K.;
RT   "MINK is a Rap2 effector for phosphorylation of the postsynaptic
RT   scaffold protein TANC1.";
RL   Biochem. Biophys. Res. Commun. 377:573-578(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640 AND SER-769, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640; SER-688; SER-720
RP   AND SER-769, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-678 AND SER-680, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19061864; DOI=10.1016/j.bbrc.2008.11.107;
RA   Uechi Y., Bayarjargal M., Umikawa M., Oshiro M., Takei K.,
RA   Yamashiro Y., Asato T., Endo S., Misaki R., Taguchi T., Kariya K.;
RT   "Rap2 function requires palmitoylation and recycling endosome
RT   localization.";
RL   Biochem. Biophys. Res. Commun. 378:732-737(2009).
RN   [16]
RP   SUBCELLULAR LOCATION, AUTOPHOSPHORYLATION, MUTAGENESIS OF LYS-54;
RP   152-ARG-ASP-153 AND 171-ASP-PHE-172, INTERACTION WITH TCF7L2 AND
RP   CTNNB1, TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=19816403; DOI=10.1038/emboj.2009.285;
RA   Mahmoudi T., Li V.S.W., Ng S.S., Taouatas N., Vries R.G.J.,
RA   Mohammed S., Heck A.J., Clevers H.;
RT   "The kinase TNIK is an essential activator of Wnt target genes.";
RL   EMBO J. 28:3329-3340(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-560; SER-640; SER-688;
RP   SER-707; SER-720; SER-766 AND SER-769, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH NEDD4 AND RAP2A.
RX   PubMed=20159449; DOI=10.1016/j.neuron.2010.01.007;
RA   Kawabe H., Neeb A., Dimova K., Young S.M. Jr., Takeda M.,
RA   Katsurabayashi S., Mitkovski M., Malakhova O.A., Zhang D.E.,
RA   Umikawa M., Kariya K., Goebbels S., Nave K.A., Rosenmund C., Jahn O.,
RA   Rhee J., Brose N.;
RT   "Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite
RT   development.";
RL   Neuron 65:358-372(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   FUNCTION.
RX   PubMed=21690388; DOI=10.1073/pnas.1104128108;
RA   Kaneko S., Chen X., Lu P., Yao X., Wright T.G., Rajurkar M.,
RA   Kariya K., Mao J., Ip Y.T., Xu L.;
RT   "Smad inhibition by the Ste20 kinase Misshapen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:11127-11132(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; SER-688 AND
RP   SER-769, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570; SER-600; SER-608;
RP   SER-610; SER-640; SER-678; SER-680; SER-688; SER-701; SER-707;
RP   SER-720; SER-764; SER-769 AND SER-959, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640 AND SER-680, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   POSSIBLE INVOLVEMENT IN MRT54.
RX   PubMed=27106596; DOI=10.1007/s00439-016-1671-9;
RA   Anazi S., Shamseldin H.E., AlNaqeb D., Abouelhoda M., Monies D.,
RA   Salih M.A., Al-Rubeaan K., Alkuraya F.S.;
RT   "A null mutation in TNIK defines a novel locus for intellectual
RT   disability.";
RL   Hum. Genet. 135:773-778(2016).
RN   [25]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-778; GLU-910 AND THR-999.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase that acts as an essential
CC       activator of the Wnt signaling pathway. Recruited to promoters of
CC       Wnt target genes and required to activate their expression. May
CC       act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the
CC       JUN N-terminal pathway. May play a role in the response to
CC       environmental stress. Part of a signaling complex composed of
CC       NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension
CC       and arborization during development. More generally, it may play a
CC       role in cytoskeletal rearrangements and regulate cell spreading.
CC       Phosphorylates SMAD1 on Thr-322. {ECO:0000269|PubMed:10521462,
CC       ECO:0000269|PubMed:15342639, ECO:0000269|PubMed:19061864,
CC       ECO:0000269|PubMed:19816403, ECO:0000269|PubMed:20159449,
CC       ECO:0000269|PubMed:21690388}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:10521462}.
CC   -!- SUBUNIT: Interacts (via the CNH domain) with RAP2A (GTP-bound form
CC       preferentially); the interaction is direct and required for the
CC       activation of TNIK by RAP2A. Interacts with NEDD4; recruits RAP2A
CC       to NEDD4. Interacts with TRAF2 and NCK. Interacts with TCF7L2/TCF4
CC       and CTNNB1; the interaction is direct. Interacts with TANC1.
CC       {ECO:0000269|PubMed:10521462, ECO:0000269|PubMed:15342639,
CC       ECO:0000269|PubMed:18930710, ECO:0000269|PubMed:19816403,
CC       ECO:0000269|PubMed:20159449}.
CC   -!- INTERACTION:
CC       P35222:CTNNB1; NbExp=3; IntAct=EBI-1051794, EBI-491549;
CC       Q6F6B3:Tanc1 (xeno); NbExp=2; IntAct=EBI-1051794, EBI-2133582;
CC       Q9NQB0:TCF7L2; NbExp=3; IntAct=EBI-1051794, EBI-924724;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Recycling endosome.
CC       Cytoplasm, cytoskeleton. Note=Associated with recycling endosomes
CC       and the cytoskeletal fraction upon RAP2A overexpression.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=Q9UKE5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKE5-2; Sequence=VSP_004889;
CC       Name=3;
CC         IsoId=Q9UKE5-3; Sequence=VSP_004890;
CC       Name=4;
CC         IsoId=Q9UKE5-4; Sequence=VSP_004891;
CC       Name=5;
CC         IsoId=Q9UKE5-5; Sequence=VSP_004889, VSP_004890;
CC       Name=6;
CC         IsoId=Q9UKE5-6; Sequence=VSP_004889, VSP_004891;
CC       Name=7;
CC         IsoId=Q9UKE5-7; Sequence=VSP_004890, VSP_004891;
CC       Name=8;
CC         IsoId=Q9UKE5-8; Sequence=VSP_004889, VSP_004890, VSP_004891;
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously. Highest levels
CC       observed in heart, brain and skeletal muscle. Expressed in normal
CC       colonic epithelia and colorectal cancer tissues.
CC       {ECO:0000269|PubMed:10521462, ECO:0000269|PubMed:19816403}.
CC   -!- PTM: Autophosphorylated. Autophosphorylation is activated by RAP2A
CC       and induces association to the cytoskeletal fraction.
CC   -!- DISEASE: Mental retardation, autosomal recessive 54 (MRT54)
CC       [MIM:617028]: A form of mental retardation, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period. MRT54 patients
CC       manifest intellectual disability, delayed speech and
CC       hyperactivity. {ECO:0000269|PubMed:27106596}. Note=The disease may
CC       be caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25477.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF172264; AAF03782.1; -; mRNA.
DR   EMBL; AF172268; AAF03786.1; -; mRNA.
DR   EMBL; AF172267; AAF03785.1; -; mRNA.
DR   EMBL; AF172266; AAF03784.1; -; mRNA.
DR   EMBL; AF172265; AAF03783.1; -; mRNA.
DR   EMBL; AF172270; AAF03788.1; -; mRNA.
DR   EMBL; AF172271; AAF03789.1; -; mRNA.
DR   EMBL; AF172269; AAF03787.1; -; mRNA.
DR   EMBL; AB011123; BAA25477.2; ALT_INIT; mRNA.
DR   EMBL; AK291056; BAF83745.1; -; mRNA.
DR   EMBL; AC026315; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078793; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092919; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC137517; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78484.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78489.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78492.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78493.1; -; Genomic_DNA.
DR   EMBL; BC019081; AAH19081.2; -; mRNA.
DR   EMBL; BC150256; AAI50257.1; -; mRNA.
DR   CCDS; CCDS46956.1; -. [Q9UKE5-1]
DR   CCDS; CCDS54673.1; -. [Q9UKE5-8]
DR   CCDS; CCDS54674.1; -. [Q9UKE5-5]
DR   CCDS; CCDS54675.1; -. [Q9UKE5-6]
DR   CCDS; CCDS54676.1; -. [Q9UKE5-2]
DR   CCDS; CCDS54677.1; -. [Q9UKE5-7]
DR   CCDS; CCDS54678.1; -. [Q9UKE5-3]
DR   CCDS; CCDS54679.1; -. [Q9UKE5-4]
DR   RefSeq; NP_001155032.1; NM_001161560.2. [Q9UKE5-4]
DR   RefSeq; NP_001155033.1; NM_001161561.2. [Q9UKE5-2]
DR   RefSeq; NP_001155034.1; NM_001161562.2. [Q9UKE5-6]
DR   RefSeq; NP_001155035.1; NM_001161563.2. [Q9UKE5-3]
DR   RefSeq; NP_001155036.1; NM_001161564.2. [Q9UKE5-7]
DR   RefSeq; NP_001155037.1; NM_001161565.2. [Q9UKE5-5]
DR   RefSeq; NP_001155038.1; NM_001161566.2. [Q9UKE5-8]
DR   RefSeq; NP_055843.1; NM_015028.3. [Q9UKE5-1]
DR   UniGene; Hs.34024; -.
DR   UniGene; Hs.723245; -.
DR   PDB; 2X7F; X-ray; 2.80 A; A/B/C/D/E=1-325.
DR   PDB; 5AX9; X-ray; 2.40 A; A/B/C=11-314.
DR   PDB; 5CWZ; X-ray; 2.90 A; A/B/C=11-314.
DR   PDB; 5D7A; X-ray; 2.90 A; A/B/C=11-314.
DR   PDBsum; 2X7F; -.
DR   PDBsum; 5AX9; -.
DR   PDBsum; 5CWZ; -.
DR   PDBsum; 5D7A; -.
DR   ProteinModelPortal; Q9UKE5; -.
DR   SMR; Q9UKE5; -.
DR   BioGrid; 116682; 43.
DR   DIP; DIP-37562N; -.
DR   IntAct; Q9UKE5; 23.
DR   MINT; MINT-7242209; -.
DR   STRING; 9606.ENSP00000399511; -.
DR   BindingDB; Q9UKE5; -.
DR   ChEMBL; CHEMBL4527; -.
DR   GuidetoPHARMACOLOGY; 2244; -.
DR   iPTMnet; Q9UKE5; -.
DR   PhosphoSitePlus; Q9UKE5; -.
DR   BioMuta; TNIK; -.
DR   DMDM; 29840818; -.
DR   EPD; Q9UKE5; -.
DR   PaxDb; Q9UKE5; -.
DR   PeptideAtlas; Q9UKE5; -.
DR   PRIDE; Q9UKE5; -.
DR   Ensembl; ENST00000284483; ENSP00000284483; ENSG00000154310. [Q9UKE5-4]
DR   Ensembl; ENST00000341852; ENSP00000345352; ENSG00000154310. [Q9UKE5-5]
DR   Ensembl; ENST00000357327; ENSP00000349880; ENSG00000154310. [Q9UKE5-2]
DR   Ensembl; ENST00000436636; ENSP00000399511; ENSG00000154310. [Q9UKE5-1]
DR   Ensembl; ENST00000460047; ENSP00000418916; ENSG00000154310. [Q9UKE5-7]
DR   Ensembl; ENST00000470834; ENSP00000419990; ENSG00000154310. [Q9UKE5-6]
DR   Ensembl; ENST00000475336; ENSP00000418156; ENSG00000154310. [Q9UKE5-8]
DR   Ensembl; ENST00000488470; ENSP00000418378; ENSG00000154310. [Q9UKE5-3]
DR   GeneID; 23043; -.
DR   KEGG; hsa:23043; -.
DR   UCSC; uc003fhh.3; human. [Q9UKE5-1]
DR   CTD; 23043; -.
DR   DisGeNET; 23043; -.
DR   GeneCards; TNIK; -.
DR   HGNC; HGNC:30765; TNIK.
DR   HPA; HPA012128; -.
DR   HPA; HPA012297; -.
DR   MalaCards; TNIK; -.
DR   MIM; 610005; gene.
DR   MIM; 617028; phenotype.
DR   neXtProt; NX_Q9UKE5; -.
DR   OpenTargets; ENSG00000154310; -.
DR   PharmGKB; PA134893180; -.
DR   eggNOG; KOG0587; Eukaryota.
DR   eggNOG; ENOG410XPHR; LUCA.
DR   GeneTree; ENSGT00810000125351; -.
DR   HOVERGEN; HBG036506; -.
DR   InParanoid; Q9UKE5; -.
DR   KO; K08840; -.
DR   OMA; TEQYNVG; -.
DR   OrthoDB; EOG091G018A; -.
DR   PhylomeDB; Q9UKE5; -.
DR   TreeFam; TF105138; -.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   SignaLink; Q9UKE5; -.
DR   SIGNOR; Q9UKE5; -.
DR   ChiTaRS; TNIK; human.
DR   EvolutionaryTrace; Q9UKE5; -.
DR   GeneWiki; TNIK; -.
DR   GenomeRNAi; 23043; -.
DR   PMAP-CutDB; Q9UKE5; -.
DR   PRO; PR:Q9UKE5; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000154310; -.
DR   ExpressionAtlas; Q9UKE5; baseline and differential.
DR   Genevisible; Q9UKE5; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB.
DR   GO; GO:0007256; P:activation of JNKK activity; IDA:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0030033; P:microvillus assembly; IMP:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; IDA:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Endosome; Kinase; Mental retardation;
KW   Neurogenesis; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Wnt signaling pathway.
FT   CHAIN         1   1360       TRAF2 and NCK-interacting protein kinase.
FT                                /FTId=PRO_0000086761.
FT   DOMAIN       25    289       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN     1047   1334       CNH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00795}.
FT   NP_BIND      31     39       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      290   1047       Mediates interaction with NEDD4.
FT                                {ECO:0000269|PubMed:20159449}.
FT   ACT_SITE    153    153       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      54     54       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     187    187       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P83510}.
FT   MOD_RES     324    324       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P83510}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     560    560       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     570    570       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     581    581       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P83510}.
FT   MOD_RES     600    600       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     608    608       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     610    610       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     640    640       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     678    678       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     680    680       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     688    688       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     701    701       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     707    707       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     720    720       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     764    764       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     766    766       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     769    769       Phosphoserine.
FT                                {ECO:0000244|PubMed:15144186,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     959    959       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     445    473       Missing (in isoform 2, isoform 5, isoform
FT                                6 and isoform 8).
FT                                {ECO:0000303|PubMed:10521462,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_004889.
FT   VAR_SEQ     537    591       Missing (in isoform 3, isoform 5, isoform
FT                                7 and isoform 8).
FT                                {ECO:0000303|PubMed:10521462,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_004890.
FT   VAR_SEQ     795    802       Missing (in isoform 4, isoform 6, isoform
FT                                7 and isoform 8).
FT                                {ECO:0000303|PubMed:10521462}.
FT                                /FTId=VSP_004891.
FT   VARIANT     778    778       K -> E (in dbSNP:rs55778284).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041231.
FT   VARIANT     910    910       G -> E (in dbSNP:rs35090763).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041232.
FT   VARIANT     999    999       A -> T (in dbSNP:rs17857452).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041233.
FT   MUTAGEN      54     54       K->A: Kinase dead. Loss of
FT                                autophosphorylation and loss of function
FT                                in cytoskeleton regulation.
FT                                {ECO:0000269|PubMed:15342639,
FT                                ECO:0000269|PubMed:19816403}.
FT   MUTAGEN     152    153       RD->AA: Loss of autophosphorylation.
FT                                {ECO:0000269|PubMed:19816403}.
FT   MUTAGEN     171    172       DF->AA: Loss of autophosphorylation.
FT                                {ECO:0000269|PubMed:19816403}.
FT   HELIX        15     17       {ECO:0000244|PDB:5AX9}.
FT   TURN         22     24       {ECO:0000244|PDB:5AX9}.
FT   STRAND       25     34       {ECO:0000244|PDB:5AX9}.
FT   STRAND       37     44       {ECO:0000244|PDB:5AX9}.
FT   TURN         45     47       {ECO:0000244|PDB:5AX9}.
FT   STRAND       50     58       {ECO:0000244|PDB:5AX9}.
FT   TURN         60     62       {ECO:0000244|PDB:5AX9}.
FT   HELIX        63     76       {ECO:0000244|PDB:5AX9}.
FT   STRAND       85     91       {ECO:0000244|PDB:5AX9}.
FT   STRAND       95     97       {ECO:0000244|PDB:5AX9}.
FT   STRAND       99    106       {ECO:0000244|PDB:5AX9}.
FT   HELIX       113    118       {ECO:0000244|PDB:5AX9}.
FT   HELIX       121    123       {ECO:0000244|PDB:5AX9}.
FT   HELIX       127    146       {ECO:0000244|PDB:5AX9}.
FT   HELIX       156    158       {ECO:0000244|PDB:5AX9}.
FT   STRAND      159    161       {ECO:0000244|PDB:5AX9}.
FT   STRAND      167    169       {ECO:0000244|PDB:5AX9}.
FT   TURN        173    175       {ECO:0000244|PDB:2X7F}.
FT   HELIX       192    194       {ECO:0000244|PDB:2X7F}.
FT   HELIX       197    199       {ECO:0000244|PDB:5AX9}.
FT   STRAND      203    207       {ECO:0000244|PDB:5CWZ}.
FT   HELIX       212    228       {ECO:0000244|PDB:5AX9}.
FT   TURN        232    235       {ECO:0000244|PDB:5AX9}.
FT   HELIX       238    247       {ECO:0000244|PDB:5AX9}.
FT   HELIX       260    269       {ECO:0000244|PDB:5AX9}.
FT   HELIX       274    276       {ECO:0000244|PDB:5AX9}.
FT   HELIX       280    283       {ECO:0000244|PDB:5AX9}.
FT   HELIX       287    290       {ECO:0000244|PDB:5AX9}.
FT   HELIX       295    306       {ECO:0000244|PDB:5AX9}.
SQ   SEQUENCE   1360 AA;  154943 MW;  3590BC2905A72C3D CRC64;
     MASDSPARSL DEIDLSALRD PAGIFELVEL VGNGTYGQVY KGRHVKTGQL AAIKVMDVTG
     DEEEEIKQEI NMLKKYSHHR NIATYYGAFI KKNPPGMDDQ LWLVMEFCGA GSVTDLIKNT
     KGNTLKEEWI AYICREILRG LSHLHQHKVI HRDIKGQNVL LTENAEVKLV DFGVSAQLDR
     TVGRRNTFIG TPYWMAPEVI ACDENPDATY DFKSDLWSLG ITAIEMAEGA PPLCDMHPMR
     ALFLIPRNPA PRLKSKKWSK KFQSFIESCL VKNHSQRPAT EQLMKHPFIR DQPNERQVRI
     QLKDHIDRTK KKRGEKDETE YEYSGSEEEE EENDSGEPSS ILNLPGESTL RRDFLRLQLA
     NKERSEALRR QQLEQQQREN EEHKRQLLAE RQKRIEEQKE QRRRLEEQQR REKELRKQQE
     REQRRHYEEQ MRREEERRRA EHEQEYIRRQ LEEEQRQLEI LQQQLLHEQA LLLEYKRKQL
     EEQRQAERLQ RQLKQERDYL VSLQHQRQEQ RPVEKKPLYH YKEGMSPSEK PAWAKEVEER
     SRLNRQSSPA MPHKVANRIS DPNLPPRSES FSISGVQPAR TPPMLRPVDP QIPHLVAVKS
     QGPALTASQS VHEQPTKGLS GFQEALNVTS HRVEMPRQNS DPTSENPPLP TRIEKFDRSS
     WLRQEEDIPP KVPQRTTSIS PALARKNSPG NGSALGPRLG SQPIRASNPD LRRTEPILES
     PLQRTSSGSS SSSSTPSSQP SSQGGSQPGS QAGSSERTRV RANSKSEGSP VLPHEPAKVK
     PEESRDITRP SRPASYKKAI DEDLTALAKE LRELRIEETN RPMKKVTDYS SSSEESESSE
     EEEEDGESET HDGTVAVSDI PRLIPTGAPG SNEQYNVGMV GTHGLETSHA DSFSGSISRE
     GTLMIRETSG EKKRSGHSDS NGFAGHINLP DLVQQSHSPA GTPTEGLGRV STHSQEMDSG
     TEYGMGSSTK ASFTPFVDPR VYQTSPTDED EEDEESSAAA LFTSELLRQE QAKLNEARKI
     SVVNVNPTNI RPHSDTPEIR KYKKRFNSEI LCAALWGVNL LVGTENGLML LDRSGQGKVY
     NLINRRRFQQ MDVLEGLNVL VTISGKKNKL RVYYLSWLRN RILHNDPEVE KKQGWITVGD
     LEGCIHYKVV KYERIKFLVI ALKNAVEIYA WAPKPYHKFM AFKSFADLQH KPLLVDLTVE
     EGQRLKVIFG SHTGFHVIDV DSGNSYDIYI PSHIQGNITP HAIVILPKTD GMEMLVCYED
     EGVYVNTYGR ITKDVVLQWG EMPTSVAYIH SNQIMGWGEK AIEIRSVETG HLDGVFMHKR
     AQRLKFLCER NDKVFFASVR SGGSSQVFFM TLNRNSMMNW
//
